NuVasive Buys Ellipse Technologies for $380Million

« Back to Industry News


Spinal device company, NuVasive, Inc. is to buy “skeletal deformities” specialist Ellipse Technologies, Inc., for a $380 million upfront cash payment and a potential $30 million milestone payable in 2017 related to the achievement of specific revenue targets.


NuVasive specialises in minimally disruptive surgical products and procedurally-integrated solutions for the spine. The company has become the third biggest player in the $9 billion global spine market and no doubt sees this acquisition as a key component in its quest to become number one. For its part, Ellipse is the developer and marketer of a novel platform of magnetically adjustable implant systems based on its MAGnetic External Control, or MAGEC®, technology. Indeed we’ve covered the technology on a number of occasions in the past few years.

Click here to read the full article.

« Back to Industry News